Merus NV (MRUS)
45.49
+1.14
(+2.56%)
USD |
NASDAQ |
Nov 22, 16:00
45.50
+0.01
(+0.02%)
After-Hours: 20:00
Merus Total Assets (Quarterly): 844.68M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 844.68M |
| June 30, 2024 | 892.23M |
| March 31, 2024 | 498.08M |
| December 31, 2023 | 455.49M |
| September 30, 2023 | 492.19M |
| June 30, 2023 | 363.62M |
| March 31, 2023 | 338.52M |
| December 31, 2022 | 376.54M |
| September 30, 2022 | 414.99M |
| June 30, 2022 | 444.79M |
| March 31, 2022 | 417.50M |
| December 31, 2021 | 456.60M |
| September 30, 2021 | 355.93M |
| June 30, 2021 | 379.58M |
| March 31, 2021 | 397.95M |
| December 31, 2020 | 231.22M |
| September 30, 2020 | 213.49M |
| June 30, 2020 | 223.66M |
| March 31, 2020 | 237.96M |
| December 31, 2019 | 263.38M |
| Date | Value |
|---|---|
| September 30, 2019 | 207.73M |
| June 30, 2019 | 228.41M |
| March 31, 2019 | 238.53M |
| December 31, 2018 | 252.97M |
| September 30, 2018 | 261.07M |
| June 30, 2018 | 268.19M |
| March 31, 2018 | 288.61M |
| December 31, 2017 | 236.10M |
| September 30, 2017 | 244.16M |
| June 30, 2017 | 255.82M |
| March 31, 2017 | 257.43M |
| December 31, 2016 | 76.05M |
| September 30, 2016 | 77.41M |
| June 30, 2016 | 81.89M |
| March 31, 2016 | 32.57M |
| December 31, 2015 | 38.81M |
| September 30, 2015 | 46.39M |
| June 30, 2015 | 8.556M |
| December 31, 2014 | 4.305M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
213.49M
Minimum
Sep 2020
892.23M
Maximum
Jun 2024
414.92M
Average
388.77M
Median
Total Assets (Quarterly) Benchmarks
| Qiagen NV | 6.270B |
| uniQure NV | 645.81M |
| ProQR Therapeutics NV | 119.34M |
| argenx SE | -- |
| Pharming Group | 425.51M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 141.42M |
| Shareholders Equity (Quarterly) | 703.26M |
| Current Ratio | 8.320 |